Actimed Therapeutics enrolls first patients in phase 2a PROACT study to assess S-pindolol benzoate in obese patients ...
Actimed Therapeutics Ltd, a UK based clinical stage specialty pharmaceutical company focused on the treatment of cancer cachexia and other muscle wasting disorders, announced that the first patients have been enrolled in the company’s phase 2a muscle …